Table 2 Patient compliance in various recent or ongoing clinical trials in resectable gastric cancer
Study [reference] | Treatment arm | Completed (%) |
|---|---|---|
SWOG [5] | S→CRT | 64% |
MAGIC [7] | CT→S→CT | 42% |
ACTS-GC [51] | S→CT | 66% |
CLASSIC [40] | S→CT | 67% |
ARTIST [59] | S→CT | 75% |
S→CRT | 82% | |
ST03 [31] | CT→S→CT | 40% |
CT + B→S→CT + B | 37% | |
TOPGEAR part 1 [27] | CT→S→CT | 58% |
CT→CRT→S→CT | 45% | |
FLOT4-AIO [14] | CT→S→CT (3×ECF/ECX) | 37% |
CT→S→CT (4×FLOT) | 50% | |
CRITICS [11] | CT→S→CT | 46% |
CT→S→CRT | 51% |